Email alerts
Advanced Search
  • Sep 28, 2021
    Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
    - Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE Mark approval for its radial artery access portfolio, which includes the Rist™ 079 Radial...

  • Sep 22, 2021
    U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges
    Medtronic Will Move to Request Litigation Proceedings Resume

    Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed an additional...

  • Sep 22, 2021
    Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis

    As First Patient Is Enrolled in the Clinical Trial of Braive™ Growth Modulation System, Study Reaffirms Medtronic's Commitment to Pediatric Spine Innovation DUBLIN, Sept. 22, 2021 /PRNewswire/...

  • Sep 13, 2021
    U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents
    Medtronic Receives Affirmation of Three Additional Sacral Neuromodulation Patents

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP) for its sacral...

  • Aug 6, 2021
    Medtronic to Acquire Intersect ENT
    Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat...

Show 5102550100 per page